United States· US:49702-242_19269bd8-a858-414a-80b5-9acba5aa9fd7
Juluca
A dolutegravir and rilpivirine product containing dolutegravir sodium; rilpivirine hydrochloride, registered in United States by ViiV Healthcare Company. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dolutegravir and rilpivirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR21 (dolutegravir and rilpivirine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Dolutegravir and rilpivirine · ATC J05AR21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
- Manufacturer
- ViiV Healthcare Company
- Country
- United States (US)
- ATC code
- J05AR21
- ATC class
- Dolutegravir and rilpivirine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1149702-242-13
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dolutegravir and rilpivirine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJULUCAViiV Healthcare BV, Amersfoort
- PolandJulucaViiV Healthcare BV
- FinlandJulucaAbacus Medicine A/S
- SpainJULUCA 50 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- FranceJULUCA 50 mg/25 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- United KingdomJuluca 50mg/25mg tabletsViiV Healthcare UK Ltd
- IcelandJulucaViiV Healthcare BV
- NetherlandsJuluca 50 mg/25 mg, filmomhulde tablettenViiV healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Juluca
- Liechtenstein · Juluca
- Norway · Juluca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4926ce96-7800-47d3-a950-29514043c5f8 GET /v1/drugs/4926ce96-7800-47d3-a950-29514043c5f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 25",
"substance": "DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE",
"productndc": "49702-242",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA210192",
"marketing_category": "NDA"
}See everything about dolutegravir and rilpivirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.